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Chemical Methods

Chemicals and instrumentation
Unless otherwise noted, chemicals were purchased from Sigma Aldrich, Merck, Okeanos, Roth or Alfa Aesar and were used without further purification. Protected Fmoc-amino acids and coupling reagents were purchased from Novabiochem and Iris Biotech GmbH. Building block 6 for hydrocarbon peptide stapling was purchased from Okeanos Tech. Co. LTD. All solvents were purchased from commercial suppliers and used without further purification. Analytical HPLC was performed using an Agilent 1100 Series with either a C18 HPLC column 3 µm (Macherey Nagel) or a C18 HPLC column 1.8 µm (Macherey Nagel). The system was run at a flow rate of 1.0 mL/min over 30 min using H 2 O (0.1% TFA) and MeCN (0.1% TFA) as solvents. Linear gradients were run over varying periods of time. HPLC-MS analyses were performed with an Agilent 1100
Series connected to a Thermo LCQ Advantage mass spectrometer using a C18 HPLC column 3 µm (Macherey Nagel). The system was run at a flow rate of 1 mL/min over 15 min using H 2 O (0.1% formic acid)
and MeCN (0.1% formic acid) as eluents. Semi preparative HPLC was carried out on a Agilent 1100 Series using a SP125/10 Nuclear C18 Gravity 5 µm column (Macherey Nagel) at a flow rate of 6 mL/min. Linear gradients using H 2 O (0.1% TFA) and MeCN (0.1% TFA) were run over varying periods of time. High resolution mass spectra were recorded on a QLT Orbitrap mass spectrometer coupled to an Acceka HPLCSystem (HPLC column: Hypersyl GOLD, 50 mm x 1mm particle size 1.9 µm, ionization method: Electrospray Ionization). Automated peptide synthesis was performed using a CEM-Discover microwave and a CEM- MicroScale Thermophoresis (MST) curves were measured on a NanoTemper Technologies Monolith NT.115.
Ring-closing alkyne metathesis
The dried resin was transferred under argon into a baked out Schlenk tube and swollen and shrunken alternating in dry diethyl ether and dry toluene (3x each). Afterwards 0.5 mL of a solution of the alkyne metathesis complex 11 (2 mg•mL -1 ) in dry toluene was added and the reaction mixture was stirred at 40°C for 1.5 h. During the reaction time argon was bubbled through the reaction mixture to evaporate the 2-butyne. After addition of 0.5 mL of fresh complex 11 solution the mixture was stirred at 40°C for 1.5 h. The resin was filtered off, washed with toluene (3x), DCM (3x) and dried to constant weight.
Ring-closing olefin metathesis
The dried resin was swollen in DCE for 15 min. A solution of Grubbs 1 st generation catalyst (2 mg•mL -1 ) in DCE was added to the resin and reacted for 2 h at room temperature. During the reaction time argon was bubbled through the reaction mixture to remove ethene. The procedure was repeated twice and the resin was washed with DCE (3x), DCM (3x), DMF (3x).
Cleavage from the resin
The dry resin was treated with a solution of TFA/EDT/TIS/H 2 O (94/1/2.5/2.5, v/v/v/v) 100 µL for 10 mg resin for 2x 1 h and 1x 5 min. The solvents were evaporated and the crude peptide was precipitated by the addition of cold diethyl ether. After centrifugation (10 min, 16.100 x g, 4°C) the supernatant was removed.
The crude product was dissolved in H 2 O/MeCN (2/1, v/v) and lyophilized. The crude peptides were purified by semi-preparative HPLC.
Fmoc quantification
A defined amount of dry resin was transferred into an Eppendorf cap and treated with 0.5 mL deprotection solution for 15 min. The UV absorption of the supernatant was determined at 305 nm and the occupation density calculated using Beer-Lambert law (ԑ = 7800 cm
).
Peptide quantification
The concentration of fluorescein labelled peptides was determined by UV absorption in 20 mM phosphate buffer (pH 8.5) at 496 nm (ԑ = 77.000 cm
). The concentration of acetylated peptides was determined gravimetrically or via UV absorption at 280 nm.
Building block synthesis
Synthetic methods
Synthesis of the alkyne building blocks 1 -5 was performed according to adapted protocols from Y. N.
Belokon et al. [1] and G. H. Bird et al. [2] Schematic representation of the synthesis is summarized below.
Synthesis of the alkyne building blocks. 
Synthesis of Mo-complex 11
Mo-complex 11 for RCAM was prepared according to previously established procedures.
[3]
Synthesis of alkyne alcohols (6a, b)
Synthesis of alkyne alcohols, hept-5-yn-1-ol (6a) and oct-6-yn-1-ol (6b), was carried out according to previously established protocols.
[4]
Synthesis of iodo-alkynes (7a, b)
The alcohols 6a, b was converted into the 7-iodohept-2-yne (7a) and 9-iodonon-2-yne (7b) following established protocols. 
Synthesis of (S, R)-Ala-Ni(II)-BPB (8a, b)
Synthesis of the Ni-complexes 8a and 8b was carried out according to previously established protocols starting either from L-or D-Proline. 
Synthesis of alkynated (S),(R)-Ala-Ni(II)-BPB (9a, b)
To a solution of 8a, b in 15 mL DMF in a baked out flask under argon, freshly ground KOH (5.0 eq.) was added and the reaction mixture stirred for 20 min at 0°C. After addition of iodo-alkynes (7a, b) (1.2 eq.) in 2 mL DMF, the mixture was stirred for 20 min at 0°C and another 2 h at room temperature. The reaction was quenched by pouring it onto chilled acetic acid (125 mL, 5%) and extracted with DCM (3 × 80 mL). The combined organic layers were washed with water (50 mL), brine and dried over MgSO 4 . After coevaporation with toluene the pure product was obtained as a red solid. Yields: 9a = 98%; 9b = 85%. 
Synthesis of unprotected -methyl--alkynyl amino acids (10a, b)
To a solution of 10a, b in MeOH (40 mL), conc. hydrochloric acid (10 eq.) was added and the reaction mixture refluxed at 80°C for 1 h. The reaction mixture was allowed to cool to room temperature and concentrated in vacuo. After addition of water (20 mL) the aqueous layer was extracted with DCM (3× 20 mL). The combined organic layers were washed with brine, dried over MgSO 4 and concentrated under reduced pressure. Recovered BPB was purified by precipitation as hydrochloric salt from acetone solution. [7] The aqueous layer was dried by lyophilization and the crude unprotected -methyl--alkynyl amino acid was used without any further purification.
Synthesis of Fmoc-protected -methyl--alkynyl amino acids (1, 2, 4)
Fmoc-protected -methyl--alkynyl amino acids 1, 2 and 4 were performed according to previously established methods.
[8]
Synthesis of Fmoc-protected -methyl--alkynyl amino acids (3, 5)
To a solution of the crude unprotected -methyl--alkynyl amino acid in H 2 O/dioxane (40 mL, 1/1, v/v), Na 2 CO 3 (4 eq.) and Fmoc-OSu (1.2 eq.) were added and stirred at room temperature for 7 d. The reaction was monitored using HPLC-MS analysis, daily and subsequently fresh Fmoc-OSu (0.5 eq.) was added. After addition of water (100 mL) the pH of the aqueous layer was set to 2-4 using aqueous hydrochloric acid and the aqueous layer was extracted with ethyl acetate (3 x 100 mL). The combined organic layers were washed with brine, dried over MgSO 4 [9] software via non-linear regression analysis of dose-response curves.
Microscale Thermophoresis (MST)
14-3-3 was serially diluted in assay buffer and treated with 10 nM fluorescein-labelled peptide. After incubation for 2 h at room temperature the mixture was soaked into capillaries for microscale thermophoresis (MST) measurements. K d values were calculated from obtained MST curves using the software Monolith Affinity Analysis (NanoTemper Technologies).
Competition fluorescence polarization assay
The half maximal inhibitory concentration (IC 50 values was realized by use of GraphPad Prism [9] software via nonlinear regression analysis of dose-response curves.
Supporting Table S1 . Detailed overview of all synthesized alkyne macrocyclic peptides based on the non-modified ESp sequence Entry Peptide N-Term mod.
[a]
Sequence HPLC (t R , [min]) [b] HRMS (Calc.) Figure S7 . A Front view on 2F o -F C electron density of peptide H (red) bound to 14-3-3 monomer (cartoon, white); B Top view on 2F o -F C electron density of peptide H (red) bound to 14-3-3 monomer (cartoon, white).
Supporting Figure S8 . Non-polar contacts between peptide H (ribbon presentation, red) and 14-3-3 (cartoon, white). Residues of 14-3-3 involved in non-polar contacts with peptide H are shown as sticks with semi-transparent (white = C, blue = N, red = O).
